Back to News
Market Impact: 0.15
ONWARD Medical Marks First Implant In EIGER Study Of ARC-IM System
Source: Nasdaq
Healthcare & BiotechCompany FundamentalsTechnology & Innovation
Onward Medical announced the first implant in its EIGER clinical feasibility study of the investigational ARC-IM System for restoring mobility in people with subacute (chronic) spinal cord injury. This milestone advances the study’s start/activation, supporting incremental clinical progress for the program.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.18
More News
- AI slowdown risks: the stocks most exposed if frontier labs pull back
- Baker Hughes sees no slowdown in energy projects despite higher rates as AI buildouts stoke LNG demand
- U.S. stock futures slide on calls to slow AI development, M.East escalation
- Z.ai shares tumble over 10% after $5 billion fundraising, its second major raise in two months
- Why is Samsung Electronics stock sliding today?
- Here are the 2 big things we're watching in this week's stock market